Tadalafil became famous for the wrong reason. Longevity physicians now prescribe it daily at low doses for endothelial health, vascular protection, and cerebral perfusion — not for erectile dysfunction. Here is the full protocol, the evidence, and what to track.
Tadalafil has a branding problem. It got famous as the drug in the Cialis ads, and that association has obscured something important: it is one of the most mechanistically compelling cardiovascular longevity compounds available, and it has 20 years of clinical safety data behind it.
Every serious longevity physician who thinks carefully about vascular health has at some point considered daily low-dose tadalafil. Many prescribe it. Not for erectile dysfunction — as a vascular maintenance protocol.
This is what you need to know.
Tadalafil is a PDE5 inhibitor. PDE5 (phosphodiesterase type 5) is an enzyme that breaks down cyclic GMP (cGMP) in smooth muscle cells. cGMP is the downstream messenger of nitric oxide — the molecule that tells your blood vessels to relax and dilate.
When PDE5 breaks down cGMP, blood vessels constrict. When tadalafil blocks PDE5, cGMP accumulates, nitric oxide signals are prolonged, and smooth muscle stays relaxed. The result is vasodilation — sustained, systemic, affecting every blood vessel in your body.
This is not a localized effect. Tadalafil at therapeutic concentrations reaches the coronary arteries, the pulmonary vasculature, the cerebral circulation, the kidneys, and skeletal muscle. Every downstream organ that depends on good blood flow benefits from sustained PDE5 inhibition.
Tadalafil's pharmacokinetics are what make the daily low-dose protocol viable. Its half-life is 17.5 hours — rising to 21.6 hours in men over 65. A single 5 mg dose produces stable plasma levels throughout a full 24-hour period, and therapeutic blood concentrations are maintained with consistent daily dosing.
Compare this to sildenafil: half-life of 4–5 hours. Sildenafil is an on-demand drug by pharmacokinetic necessity. Tadalafil can be a continuous maintenance drug, which changes the clinical rationale entirely.
The 5 mg daily dose is FDA-approved for benign prostatic hyperplasia. It has been studied in that population specifically because researchers needed to understand endothelial and cardiovascular effects at this dose in older men. The endothelial data from those trials is what first caught the attention of longevity physicians.
Endothelial dysfunction is the earliest measurable sign of cardiovascular disease — it precedes atherosclerosis, coronary artery disease, heart attacks, and stroke by years, sometimes by a decade. Flow-mediated dilation (FMD) of the brachial artery is the non-invasive gold-standard measurement.
A randomized controlled trial published in Sexual Medicine (PMID 33818935, 2021) compared daily 5 mg tadalafil versus 20 mg on-demand in 60 male patients with erectile dysfunction and concomitant cardiovascular pathology. Daily 5 mg was superior on every endothelial outcome: nitric oxide increased, endothelin-1 (a vasoconstrictor) decreased, and both vascular stiffness and FMD indices improved significantly.
An earlier 2005 RCT in European Urology (PMID 15661417) enrolled men with more than two cardiovascular risk factors and a 10-year CVD risk exceeding 20%. Tadalafil significantly improved brachial artery FMD, raised circulating nitric oxide, and lowered endothelin-1. These are not surrogate endpoints — endothelin-1 and FMD independently predict hard cardiovascular events.
The most compelling recent evidence moves beyond surrogate markers to actual events.
Kloner et al. 2024 (Clinical Cardiology): A retrospective cohort of more than 29,000 men in a US commercial insurance database. Men using tadalafil had significantly lower rates of major adverse cardiovascular events (MACE) and all-cause mortality compared to non-users. Critically, there was a dose-response relationship — men with the highest cumulative tadalafil exposure had an HR of 0.40 for MACE. That is a 60% reduction in composite cardiovascular events in the highest-exposure group.
TriNetX Analysis 2024 (American Journal of Medicine): 50 million US men in the TriNetX database. PDE5 inhibitor use — tadalafil and sildenafil — was associated with significantly reduced all-cause mortality, cardiovascular disease, and dementia over a 3-year follow-up. The size of this database is what makes this analysis difficult to dismiss as confounded.
Soulaidopoulos et al. 2024 (European Heart Journal Cardiovascular Pharmacotherapy): Systematic review and meta-analysis of RCTs and observational studies. PDE5 inhibitor use associated with a 22% reduction in MACE and a 30% reduction in all-cause mortality in men with elevated baseline cardiovascular risk.
These are not small pilot studies. They are some of the largest cardiovascular dataset analyses in the field.
Your endothelium is a single-cell-thick lining covering approximately 60,000 miles of vasculature. It is 7 trillion cells. It is also one of the most metabolically active tissues in the body — producing nitric oxide, regulating clotting factors, modulating inflammation, and controlling vascular tone in real time.
When the endothelium is healthy, everything downstream works. Oxygen delivery is efficient, blood pressure is controlled, inflammatory signaling is suppressed, and organ function is preserved. When endothelial function degrades — which it does with age, with oxidative stress, with insulin resistance, and with hypertension — every organ downstream begins to dysfunction.
This is why endothelial health is one of the single strongest predictors of how long people live and how well they function in their final decades. It is not a peripheral biomarker. It is central.
Daily tadalafil addresses this directly, at the mechanistic level, through the NO/cGMP pathway.
Your brain receives 20% of cardiac output despite being 2% of body weight. It is the most metabolically demanding organ per gram and the most sensitive to changes in blood flow.
PDE5 inhibitors have been studied specifically for vascular dementia — cognitive decline caused by chronically reduced cerebral blood flow. The TriNetX 2024 analysis found PDE5 inhibitor use associated with reduced dementia incidence. The mechanism is straightforward: better endothelial function → better cerebrovascular reactivity → better cerebral perfusion → better cognitive substrate delivery.
Users consistently report improvements in mental clarity, processing speed, and sustained focus that are inconsistent with the drug's pharmacology being purely sexual. These reports align with the cerebral perfusion mechanism.
Daily low-dose is the vascular protocol. This is not the ED on-demand protocol.
The NO/cGMP pathway has upstream inputs that can be optimized alongside tadalafil's downstream protection:
L-Citrulline (3–6 g/day): The most effective oral precursor for endogenous nitric oxide synthesis. Citrulline converts to arginine, which is the substrate for eNOS (endothelial nitric oxide synthase). Tadalafil protects the downstream cGMP signal; L-Citrulline feeds the upstream NO production. These are complementary, not redundant.
Zone 2 cardio (3–5 hours/week): Sustained aerobic exercise upregulates eNOS expression through fluid shear stress on endothelial cells. This is mechanistically synergistic with tadalafil — exercise trains the endothelium to produce more NO; tadalafil ensures that NO signal is sustained downstream.
Omega-3 fatty acids (2–4 g EPA+DHA/day): Reduces endothelial inflammatory tone and supports the lipid environment of vascular cell membranes. A well-established cardiovascular co-intervention.
ABSOLUTE contraindication: nitrates in any form. Nitroglycerin, isosorbide mononitrate, isosorbide dinitrate, and amyl nitrate ("poppers") combined with any PDE5 inhibitor cause a potentially life-threatening drop in blood pressure. This combination is an emergency.
Also contraindicated or requiring caution:
Outside of these, tadalafil has a well-established safety profile from 20 years of clinical use in millions of patients. The 5 mg daily dose has a meaningfully milder side-effect profile than the 10–20 mg on-demand doses — headache and facial flushing, the most common early effects, typically resolve within 2 weeks.
Tadalafil is prescription-only. The longevity protocol requires physician involvement, which is appropriate given the contraindication profile. Telehealth platforms with physician oversight (Maximus, Hone Health, and similar men's health telehealth services) routinely prescribe it off-label for cardiovascular health. A standard annual physical with a cardiovascular risk assessment is a reasonable basis for the conversation.
Compounded generic tadalafil from legitimate compounding pharmacies runs approximately $1–2 per day at 5 mg — substantially cheaper than brand-name Cialis.
Is this just for men with erectile dysfunction?
No. The cardiovascular rationale applies equally to men without any sexual dysfunction. Several longevity physicians prescribe it specifically to men (and some women) with no sexual health concerns at all — purely for the vascular benefits. The ED association is a branding artifact of how the drug was originally marketed, not a reflection of its pharmacology.
Is there any evidence for tadalafil in women?
The endothelial mechanism is the same in women — PDE5 is expressed in female vascular tissue. Studies in pulmonary arterial hypertension (in which tadalafil is FDA-approved) include women and show consistent vascular benefit. Off-label use in women for cardiovascular longevity is less common but mechanistically supported.
Does it interfere with exercise?
There is no evidence that tadalafil blunts exercise adaptation (unlike metformin, which has data suggesting it may reduce some exercise-induced signaling). If anything, the improved muscle perfusion from sustained vasodilation may support exercise performance and recovery.
Can I take it with statins?
Yes — no known clinically significant pharmacokinetic interaction between tadalafil and statins. Both are commonly co-prescribed for cardiovascular health. Check with your physician or pharmacist if you are on multiple medications.
What blood tests should I check before starting?
At minimum: blood pressure measurement, basic metabolic panel (kidney function), liver function (tadalafil is hepatically metabolized), and a full cardiovascular risk assessment. Some longevity physicians also measure FMD at baseline to track endothelial response over time.